Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01504061 · ClinicalTrials.gov registry record · NA
Mederma to Reduce Appearance of Post Surgical Scars
A NA study, sponsored by Merz North America.
- Completed
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT01504061 is a NA study that has completed, run by Merz North America. The registered enrollment target is 20 participants.
The verdict
NCT01504061, a NA study, has completed, sponsored by Merz North America.
- COMPLETED
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N\&I to Mederma Ultra Gel on the appearance of post-surgical scars.
Interventions
- OTHER Mederma N&I
- OTHER Mederma Ultra Gel
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01504061
The ClinicalTrials.gov registry entry for NCT01504061 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Merz North America, which has 35 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Mederma N&I is the first listed.
NCT01504061 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01504061 about?
NCT01504061 is a clinical study titled "Mederma to Reduce Appearance of Post Surgical Scars". This is a single-center, 20-subject, investigator-blinded study to evaluate the effect of Mederma N\&I to Mederma Ultra Gel on the appearance of post-surgical scars.
What is the current status of trial NCT01504061?
This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2012-01. Estimated completion is 2012-08.
What interventions are being tested in trial NCT01504061?
The interventions under investigation include: Mederma N&I (OTHER), Mederma Ultra Gel (OTHER).
Who is sponsoring clinical trial NCT01504061?
This trial is sponsored by Merz North America, which has 35 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.